A saponin-rich extract of Phytolacca dioica L. berries, its acid hydrolysate, and its major aglycone, phytolaccagenin, were assayed for antifungal activity against ATCC standard cultures of Candida albicans and Cryptococcus neoformans, and against clinical isolates of these fungi. The activity of the extract was either low or negligible, but the hydrolysate, containing the sapogenins, including phytolaccagenin, and also pure phytolaccagenin, showed promising antifungal potency. Hydrolysis of a natural product extract is shown to be a useful modification leading to improved bioactivity.
Invasive fungal infections are a major cause of morbidity and mortality in immunocompromised patients [1, 2] . Although there appears to be a plentiful armamentarium of antifungal drugs in clinical use, in fact only a modest number of drugs are available [3] . In addition, they show undesirable toxicity, and either facilitate recurrence or lead to the development of resistance due, in part, to the intensive prophylactic use of antifungal drugs [4] . There is, therefore, a clear and urgent need for the discovery of new alternative compounds for antifungal therapy [5] . Plants provide unlimited opportunities for the isolation of new antifungal products because of their unmatched chemical diversity [6, 7] . In fact, numerous antifungal compounds have been isolated from them [8] [9] [10] [11] [12] [13] , including some natural saponins that have demonstrated either strong or at least modest activity [14] [15] [16] [17] .
The plant genus Phytolacca is well known as a source of triterpenoid saponins containing aglycones with oleanolic acid-derived structures (oleanolic [18] , phytolaccagenic [19, 20] , serjanic [21] , jaligonic [22] and esculentagenic [23] acids, hederagenin [24] , bayogenin [25] and phytolaccagenin [21, 25, 26] ).Among the species of this genus, P. dioica L. has been shown to contain the bidesmosidic saponins esculentoside S and esculentoside L 1 [27] , which are glycosides of phytolaccagenic acid and phytolaccagenin, respectively (Figure 1 ), the major sapogenins of this plant [28] . Liberto et al. [29, [31] [32] [33] , P. esculenta [22, 31] , P. dodecandra, P. acinosa [29] and P. tetramera [26] , and phytolaccoside E {3-O-(β−D-glucopyranosyl-(1→4)-β−D-xylopyranosyl)-phytolaccagenin = phytolaccasaponin E = esculentoside A} produced by P. americana [33, 34] and P. esculenta [31] , showed activity against the plant pathogen Cladosporium herbarum [34] , and against a panel of human opportunistic yeasts and molds [26] . In addition, recent studies have demonstrated that phytolaccoside B alters the morphology of the fungal cell wall by increasing the amount of chitin and thus causing the death of the fungus [35] .
It is worth noting that the antifungal activities exhibited by saponins of the genus Phytolacca might be useful for the development of antifungal drugs and agrochemicals. Nevertheless, although it is clear that saponins represent an interesting platform for the development of antifungal compounds, it is also well known that their complex chemical structures demand sophisticated techniques for their isolation and structure elucidation [16] . Since it has been reported recently that the chemical transformation of natural product mixtures to generate chemically engineered extracts can be an entry point to discover bioactive compounds [37, 38] , the saponin-rich n-butanol extract of P. dioica berries was subjected to acid hydrolysis This is expected to produce a sapogenin-enriched mixture, reducing the molecular weight and increasing the average lipophilicity of its constituents. Consequently, the generated compounds should have better chances of entering the fungal membrane, as compared with the original natural components, and exert their effects either there or in the cytoplasm.
The n-butanol extract (BE) of P. dioica berries, as well as its acid hydrolysate (BH), were tested against Candida albicans ATCC 10231 and Cryptococcus neoformans ATCC 32264, using the microbroth dilution assay. The relevance of these fungi to the epidemiology of fungal infections is well known. Candidiasis is now the fourth most prevalent blood-stream infection in immunocompromised hosts, C. albicans representing more than 60% of isolates from clinical infections [2] . In turn, C. neoformans remains an important lifethreatening complication, particularly for patients who have undergone transplantation of solid organs, and, therefore, new compounds acting against this fungus are highly welcome [39] .
Results showed that BE did not display any activity at concentrations up to 250 μg/mL (Table 1, line 1), but, in contrast, BH showed promising antifungal activities against the same yeasts. In order to get a closer look at the differences in antifungal properties among BE, BH, and PG, we assayed the three samples in a new panel consisting of six clinical isolates of C. albicans and ten of C. neoformans, obtained from immunocompromised patients.
The MIC values of the three samples were determined against this extended panel by using three endpoints MIC 100 , MIC 80 and MIC 50 (the minimum concentration of compounds that inhibits 100, 80 and 50 % of growth, respectively) ( Table 2 ). The application of less stringent endpoints, such as MIC 80 and MIC 50 , has been shown consistently to represent the in vitro activity of compounds [40] and often provides a better correlation with other measurements of antifungal activity [41] .
Results showed that BE was almost inactive (MIC ≥ 250 μg/mL) against the whole panel listed in In conclusion, (a) acid hydrolysis of the either inactive or marginally active n-butanol extract of P. dioica berries (BE) led to a mixture containing sapogenins (BH, where phytolaccagenin and phytolaccagenic acid are presumably the major constituents [28] ), which was not only more active against the standard fungal strains, but also against the clinical isolates of C. albicans and C. neoformans; (b) phytolaccagenin was responsible for practically all the activity of BH, as the difference observed in the activity of both samples for all isolates was in no case more than one two-fold dilution; (c) C. neoformans proved to be more sensitive than C. albicans to the P. dioica sapogenins and to pure phytolaccagenin.
This work demonstrates that the hydrolysis of a saponin-rich extract led to a new mixture with stronger and promising activities that could open new avenues for the discovery of novel antifungal agents. In addition, the work provides new evidence that the chemical modification of a natural product extract can lead to mixtures with improved properties that can be used as sources of bioactive compounds [37] . to obtain phytolaccagenin in sufficient quantity for the biological assays. The purity (> 95%) and identity of phytolaccagenin were established by TLC and HPLC, and by one-and two-dimensional 1 H and 13 C NMR spectroscopy.
Experimental

Plant material and chemistry:
Microorganisms and media:
For the microbroth dilution method, standard strains (C. albicans ATCC 10231, C. neoformans ATCC 32264) were obtained from the American Type Culture Collection, Rockville, MD, USA. Six clinical isolates of C. albicans and 10 of C. neoformans were kindly provided by the Centro de Referencia en Micología (C, CEREMIC, Rosario) and the Malbrán Institute (IM, Av. Vélez Sarsfield 563, Buenos Aires). Their voucher numbers are presented in Table 2 . They were grown on Sabouraudchloramphenicol agar slants for 48 h at 30ºC, maintained on slopes of Sabouraud-dextrose agar (SDA, Oxoid), and sub-cultured every 15 days to avoid pleomorphic transformations. Inocula were obtained according to reported procedures [40, 41] and adjusted to 1-5 × 10 3 cells/spores with colony forming units (CFU/mL).
Antifungal susceptibility tests:
Minimum inhibitory concentrations (MIC) of BE, BH, and PG were determined by using broth microdilution techniques according to the guidelines of the CSLI (formerly NCCLS) [40] . MIC values were determined in RPMI-1640 (Sigma, St. Louis, MO, USA) buffered to pH 7.0 with MOPS. Microtiter trays were incubated at 30ºC in From these data, MIC 80 and MIC 50 were determined. They were defined as the lowest concentration of either BH or PG that showed 80% or 50% reduction of growth, respectively.
Bioautography: BE, BH and PG were analyzed in duplicate by TLC. One of the plates was sprayed with anisaldehyde/sulfuric acid reagent followed by heating at 100ºC for 5-10 min to visualize the spots [42] . The other plate was bioautographed as follows: warm agar-Sabouraud medium with 0.02% phenol red (1 mL/cm 2 ) containing a C. neoformans ATCC 32264 inoculum of 1-4 × 10 5 cells/mL, quantified in accordance with reported procedures [43, 44] , was distributed over the developed TLC plate. After solidification of the medium, the plate was put into a sterile Petri dish, covered, and incubated overnight at 28ºC. Subsequently, the bioautogram was sprayed with an aqueous solution (1 mg/mL) of MTT (methylthiazolyltetrazolium chloride) and incubated for 2 h at 28ºC. Yellow inhibition zones appeared against a dark brown background [44] .
